Company intelligence / Profile preview

Jinhua Yinhe Biological Technology

Ownership: Private
Development stage: Commercial

Overview

Jinhua Yinhe Biological Technology manufactures probiotics that have been evaluated in clinical research for their effects on gut microbiota and skin conditions such as rosacea. Their products meet ISO9001 and HALAL standards and have demonstrated efficacy in modulating gut flora and improving quality of life in human studies.

Therapeutic areas: GastroenterologyDermatology
Modalities: Live biotherapeutic product therapyProbiotic
Industry: Non-Drug Biotech

Drug pipeline

1 asset

Probio-Eco

Commercial

Indications: Chronic constipation

Partnerships

Collaborates with academic researchers for clinical trials using its probiotic products

Beyond the preview

Go deeper on Jinhua Yinhe Biological Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinhua Yinhe Biological Technology.

Explore the full profile